Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report

Background: Merkel-cell carcinoma (MCC) is a rare, highly aggressive skin cancer typically involving elderly people. Surgery is usually the first treatment for primary tumor. In adjuvant setting, radiotherapy is effective in reducing local recurrence and in improving overall survival. Regarding adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Guida, Michele, D'Alò, Alessandro, Mangia, Anita, Di Pinto, Federica, Sonnessa, Margherita, Albano, Anna, Sciacovelli, Angela, Asabella, Artor Niccoli, Fucci, Livia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358364/
https://www.ncbi.nlm.nih.gov/pubmed/32733801
http://dx.doi.org/10.3389/fonc.2020.01073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358364/
https://www.ncbi.nlm.nih.gov/pubmed/32733801
http://dx.doi.org/10.3389/fonc.2020.01073

Ejemplares similares